OÜ INNOMEDICA
bd_70d45d732b131085 · schema v1 · pii pii-v1
Full breach record for OÜ INNOMEDICA →Threat-actor claim — not a regulatory filing
This row is a claim by the ransomware group Worldleaks on its public extortion blog. It has not been validated by the victim or any regulator. Treat attribution and counts as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Source: Ransomware.live
Post text · scraped from the leak site
InnoMedica is a Swiss-based biopharmaceutical firm focused on the development of tailored treatments for serious conditions such as cancer and neurological disorders. Its primary product, Talidox, is a nanomedical cancer drug that targets only tumor cells. InnoMedica's research is focused towards the technological advancements in medicine to provide more effective treatments.
Source provenance
- Source URL
- https://www.ransomware.live/id/SW5ub01lZGljYUB3b3JsZGxlYWtz
DisclosureLens links to the originating regulator URL — full filing bodies are not redistributed from public surfaces (§4.5).
- Filed at
- May 26, 2025
- Raw hash
- 261b0b5fe16eec0aee355ccc50521222dfc26353ec0b360fb51b39aea7a2409b
Reporting entity
- Name
- worldleaks
Victim entity
- Name
- OÜ INNOMEDICAnorm: ou innomedica
- Domain
- innomedica.com
- Industry
- Healthcarellm
What this source establishes
- Source ceiling
- A leak-site claim can't tell us: discovery date · materiality · notification · affected count · confirmed data types · compliance clock. These stay blank until a regulatory filing or victim disclosure lands.
- Attack vector
- Ransomware· worldleaks
- Threat actor
- WorldleaksExternalFinancial
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.